Continuous hyperfractionated accelerated radiotherapy weekend-less (CHARTWEL) in non small-cell lung cancer (NSCLC)

被引：0
|
作者：
Roth, BM
Bonomi, MR
Cerchetti, L
Pogany, C
Zaderajko, M
Brosio, C
机构：
来源：
RADIOLOGY | 2001年 / 221卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：173 / 174
页数：2
相关论文
共 50 条
  • [21] Dose-escalation with CHARTWEL (Continuous Hyperfractionated Accelerated Radiotherapy Week-End Less) combined with neo-adjuvant chemotherapy in the treatment of locally advanced non-small cell lung cancer
    Saunders, MI
    Rojas, A
    Lyn, BE
    Wilson, E
    Phillips, H
    CLINICAL ONCOLOGY, 2002, 14 (05) : 352 - 360
  • [22] Continuous Hyperfractionated Accelerated Radiotherapy (CHART) for Non-small Cell Lung Cancer (NSCLC): 7 Years' Experience From Nine UK Centres
    Sanganalmath, P.
    Lester, J. E.
    Bradshaw, A. G.
    Das, T.
    Esler, C.
    Roy, A. E. F.
    Toy, E.
    Lester, J. F.
    Button, M.
    Wilson, P.
    Comins, C.
    Atherton, P.
    Pickles, R.
    Foweraker, K.
    Walker, G. A.
    Keni, M.
    Hatton, M. Q.
    CLINICAL ONCOLOGY, 2018, 30 (03) : 144 - 150
  • [23] Sequential chemotherapy and continuous hyperfractionated accelerated radiotherapy (CHART) for non-small cell lung cancer (NSCLC): experience from nine UK centres
    Bradshaw, A. G.
    Lester, J. E.
    Das, T.
    Esler, C.
    Branagan, J.
    Roy, A. E. F.
    Toy, E. W.
    Alip, A.
    Lester, J. F.
    Williams, R.
    Kinsman, J.
    Comins, C.
    Atherton, P.
    Knox, C.
    Morgan, S.
    Walker, G. A.
    Hatton, M. Q.
    LUNG CANCER, 2014, 83 : S54 - S54
  • [24] Accelerated hyperfractionated radiotherapy weekend less (CHARTWEL) in combination with cisplatin and vinorelbine versus conventional radiotherapy combined with the same drugs in the treatment of locally advanced (stage IIIA and IIIB) NSCLC
    El Mesidi, S.
    Hassan, A. Ali
    Moussa, M.
    Makar, W.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [25] Continuous hyperfractionated accelerated radiotherapy (CHART) in non small cell lung cancer: A single centre experience as standard treatment
    Hatton, M
    Omar, D
    Fisher, P
    Peter, P
    Mohanamurali, K
    LUNG CANCER, 2005, 49 : S307 - S307
  • [26] Non-small cell lung cancer and CHART (Continuous Hyperfractionated Accelerated Radiotherapy) - where do we stand?
    Eakin, RL
    Saunders, MI
    ULSTER MEDICAL JOURNAL, 2000, 69 (02): : 128 - 136
  • [27] Radiation pneumonitis following treatment of non-small-cell lung cancer with continuous hyperfractionated accelerated radiotherapy (CHART)
    Jenkins, P
    D'Amico, K
    Benstead, K
    Elyan, S
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 56 (02): : 360 - 366
  • [28] Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: A randomised multicentre trial
    Saunders, M
    Dische, S
    Barrett, A
    Harvey, A
    Gibson, D
    Parmar, M
    LANCET, 1997, 350 (9072): : 161 - 165
  • [29] Continuous hyperfractionated accelerated radiotherapy (CHART) for patients with inoperable non-small cell lung Cancer (NSCLC): 10 year experience of the Exeter Oncology Centre
    Alip, A.
    Toy, E. W.
    LUNG CANCER, 2011, 71 : S35 - S35
  • [30] High-dose hyperfractionated accelerated radiotherapy in non-small cell lung cancer
    De Ruysscher, D.
    Reymen, B.
    Van Baardwijk, A.
    MINERVA CHIRURGICA, 2011, 66 (04) : 341 - 345
12345